Deficiency in TREM2 exacerbates outcomes after ischemic stroke by diminishing efferocytosis of dying neurons and microglia, underscoring its pivotal role over circulating macrophages in ischemic conditions (114). This evidence concerns the gene TREM2 and ischemic stroke.